ul. Poznanska 12
Macierzysz
Ozarów Mazowiecki 05-850
Poland
48 22 721 4000
https://www.bioton.pl
Secteur(s): Healthcare
Secteur d’activité: Biotechnology
Employés à temps plein: 355
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Jeremy Launders | President of the Management Board | S.O. | S.O. | S.O. |
Mr. Adam Tomasz Polonek | Member of Management Board | S.O. | S.O. | 1976 |
Ms. Anna Grabowska | Senior Finance Manager | S.O. | S.O. | S.O. |
Mr. Michal Deptuch | Operations Director | S.O. | S.O. | S.O. |
Renata Prokopczyk | Chief Accountant | S.O. | S.O. | S.O. |
Ms. Kamila Musnicka | Director of Legal Department | S.O. | S.O. | S.O. |
Mr. Mateusz Patryk Kosecki | Head of Biolek Business Unit & CEO of Biolek Sp. Z O.O. | S.O. | S.O. | 1975 |
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
L’ISS Governance QualityScore de BIOTON S.A. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..